Anesthesiology Review Course with CME


Release Date: December 1, 2017
Expiration Date: December 1, 2019

Provided by

Intended Audience

This educational program is intended for residents in anesthesiology, practicing anesthesiologists, CRNAs in training or practice, and other anesthesia care professionals interested in a thorough review and update in the practice of anesthesiology.

Statement of Need

Practicing anesthesiologists, anesthesiology residents, and practicing CRNAs require a thorough periodic review of our specialty's core information. Dannemiller has organized such a review of this body of information by drawing on the opinions of expert anesthesiology educators, as well as feedback from anesthesia professionals and participants at previous Dannemiller programs. Based on this information, this course has been designed to provide an in-depth, state-of-the-art review of the practice of anesthesia.

Learning Objectives

The overall goal of this course is to provide a comprehensive review of the specialty of anesthesiology. This course is intended for residents, practicing anesthesiologists and CRNAs seeking a comprehensive review of the specialty's core body of knowledge.

Upon completion of this activity, the participant should be able to:

  • Describe the workings and the inherent hazards of common anesthesia administration and monitoring equipment.
  • Explain and apply pharmacokinetic and pharmacodynamic principles in the administration of intravenous and inhaled anesthetics.
  • Discuss the physiology and pharmacology of neuromuscular blockade.
  • Describe the mechanisms of normal coagulation and common anticoagulants, and describe the infectious and non-infectious hazards of transfusion.
  • Explain the indications and techniques, including ultrasound, for upper and lower extremity regional blocks.
  • Discuss assessment of the respiratory system prior to pulmonary resection surgery; describe intraoperative management and post operative analgesia for thoracic surgery.
  • Illustrate the preoperative evaluation and intraoperative management of patients with various endocrinopathies including diabetes and thyroid disease.
  • Define the essential elements of transitional/ neonatal physiology; describe the anesthetic management of common and neonatal and pediatric emergencies.
  • Describe the techniques for anesthesia and analgesia for vaginal and caesarean delivery; describe the management of obstetrical emergencies.
  • Explain the evaluation and management of patient with coronary and valvular disease; describe the anesthetic management techniques for on and off pump cardiac surgery.
  • Assess the physiology and pharmacology relevant to neuroanesthesia; explain the anesthetic management for aneurysm, posterior fossa lesions, and head injury surgery.
  • Summarize the pathophysiology and treatment of sepsis, acute lung injury, and multi-organ failure.
  • Compare the physiology of normal and neuropathic pain; explain the clinical management of acute, chronic, and cancer related pain.
  • Recommend approaches to airway management and hemodynamic resuscitation of the trauma victim.
  • Demonstrate ultrasound techniques and procedures in regional, vascular and cardio-thoracic in the upper and lower regions.

Topic-specific learning objectives are listed at the beginning of each lecture.

Method of Participation

This activity should take approximately 40.00 hours to complete but learners may take the sessions at their own pace; the system will automatically save a participant's progress. Participants should first read the objectives and other introductory CE information before proceeding to the educational activity. To receive credit for this activity, participants must complete a post-test with a score of no less than 80%. No re-tests will be allowed if the participant scores less than 80%. Credit is provided through December 1, 2019. No credit will be given after this date.

In the event you have questions about this activity or are unable to retrieve the certificate, please e-mail and a certificate will be emailed within 2 weeks.

System Requirements

  • Computer or smart phone with internet access
  • Web Browser (IE 7.0+ or Webkit/Mozilla Compatible) with JavaScript enabled
  • HTML5 compatible browser or Adobe Flash Player


In support of improving patient care, Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Dannemiller designates this enduring material for a maximum of 40.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Anethetists

This program has been prior approved by the American Association of Nurse Anesthetists for 40.00 Class A CE credits; Code Number 1035501; Expiration Date 12/1/2019.

AANA designates this program as meeting the criteria for up to 5.00 CE Credits in pharmacology/ therapeutics.

ABA MOCA® Part 2

This activity fulfills the general CME requirement for MOCA Part 2.


James G. Ramsay, M.D.

Course Director
Professor of Anesthesiology
University of California San Francisco
San Francisco, California

Jerrold H. Levy, M.D.

Professor of Anesthesiology
Duke University School of Medicine
Durham, North Carolina

James B. Eisenkraft, M.D.

Professor of Anesthesiology
Mount Sinai School of Medicine
New York, New York

Pamela Flood, M.D.

Professor of Anesthesiology
Professor of Perioperative and Pain Medicine
Stanford School of Medicine
Stanford University
Stanford, California

J. Matthed Aldrich, M.D.

Associate Professor, Dept. of Anesthesi
University of California Medical School

Francis Chung, M.D.

Medical Director - Combined
Surgical Unit & Ambulatory
Surgical Unit
University of Toronto
Toronto, Ontario, Canada

Steven L. Shafer, M.D.

Professor of Anesthesiology
Perioperative and Pain Medicine
The Stanford University Medical Center
Stanford, California

John C. Drummond, M.D., FRCP(C)

Professor of Anesthesiology
University of California at San Diego
Staff Anesthesiologist
VA Medical Center
San Diego, California

Peter D. Slinger, M.D., FRCP(C)

Professor, Department of Anesthesia
University of Toronto
Toronto General Hospital
Toronto, Ontario, Canada

John C. Rowlingson, M.D.

Professor of Anesthesiology and
Director of Acute Pain Management Services
University of Virginia Health System
Charlottesville, Virginia

Kenneth D. Candido, M.D.

Professor of Anesthesiology
Professor and Chairman
Department of Anesthesiology
Advocate Illinois Masonic Medical Center
Chicago, Illinois

Benjamin J. Wallisch, D.O.

Associate Professor/Department of Anesthesiology
University of Texas Health Science Center
San Antonio, Texas

Ronald B. Easley, M.D.

Associate Professor of Pediatric Anethesiology
UT Southwestern
Baylor College of Medicine
Director - Pediatric Anesthesia Fellowship
Texas Children's Hospital
Houston, Texas


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person, who is in a position to control the content of a CME activity, must disclose all relevant financial relationships they have with a commercial interest.

The following faculty stated they have no financial relationships with commercial interests: Matt Aldrich, MD; Kenneth Candido, MD; John C. Drummond, MD; Ronald Blaine Easley, MD; James B. Eisenkraft, MD; Pamela Flood, MD; James Ramsay, MD; Peter Slinger, MD; and Benjamin J. Wallisch, MD.

The following faculty members have financial relationships with commercial interests: Frances Chung, MD – ResMed Foundation Investigator, STOP-Bang Questionnaire Investigator; Jerrold H. Levy, MD – BI, CSL Behring, Grifols, Instrumentation Labs, & Janssen Consultant/Advisory Board; John Rowlingson, MD – Adynxx Consultant; and Steven L. Shafer, MD – Medicines Company Consultant and Advisory/Medical Board, Concentric Analgesics Consultant and Advisory/Medical Board and Stockholder, Expanesthetics Advisory/Medical Board, Resq Pharma Consultant and Advisory/Medical Board, & Fresenius Consultant;

James G. Ramsay, MD, content reviewer; Scott Courtney, Audio Video; Maria Courtney, Meetings Coordinator and Amber Johnston, Dannemiller project manager have no financial relationships with commercial interests.

To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.

Off Label Statement

Off label statement provided: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.